A M Badger

Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function.

A M Badger, Jeremy N. Bradbeer, Bartholomew J. Votta et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 499 citations

SB 239063, a Second-Generation p38 Mitogen-Activated Protein Kinase Inhibitor, Reduces Brain Injury and Neurological Deficits in Cerebral Focal Ischemia

Frank C. Barone, Elaine Irving, Aparajita Ray et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 216 citations

Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists.

Don E. Griswold, Sarah Alessi, A M Badger et al. · The Journal of Immunology · 1984 · 97 citations · Full text

Inflammation, Allergy, Histamine Type 2 +14

Preclinical development of keliximab, a Primatized™ anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies

P J Bugelskil, D J Herzykl, Sabine Rehm et al. · Human & Experimental Toxicology · 2000 · 72 citations

Identification and initial characterization of 5000 expressed sequenced tags (ESTs) each from adult human normal and osteoarthritic cartilage cDNA libraries

Sanjay Kumar, J.R. Connor, Robert A. Dodds et al. · Osteoarthritis and Cartilage · 2001 · 61 citations · Full text

Bioinformatics, Systems Biology, Musculoskeletal Research +11